RxDoctor Payments Data

Brittney Cato, APRN

Family · Heber Springs, ARNPI 1972016558

Payments from drug & device makers

$438in general payments, 2019–2025

Across 23 payments — averaging $19.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$113
  • AbbVie$107
  • Lundbeck LLC$52
  • Axsome Therapeutics, Inc.$50
  • Abbott$42
  • Neurocrine Biosciences, Inc.$17
  • plus $57 from 4 others

What the payments were for

  • Food & beverage$438100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$438 in reported general payments places this provider in the 50th percentile of 2,103 family providers in Arkansas.

See all family providers in Arkansas

Medicare billing

Part B allowed, 2024
$1,699
Medicare patients
52
Services billed
116

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin93$107,762
OzempicSemaglutide75$70,532
Trelegy ElliptaFluticasone/Umeclidin/Vilanter52$35,690
MounjaroTirzepatide18$18,969
Tresiba Flextouch U-100Insulin Degludec22$13,832
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$5,136
Semglee (Yfgn) PenInsulin Glargine-Yfgn11$3,123
Albuterol Sulfate HfaAlbuterol Sulfate80$2,960
SymbicortBudesonide/Formoterol Fumarate12$2,779
Ventolin HfaAlbuterol Sulfate34$1,884
Gabapentin123$1,764
Omeprazole89$1,671
Novolog FlexpenInsulin Aspart12$1,624
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$1,534
Pregabalin12$1,094

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$14$107,76293 claims
GSKTrelegy Ellipta, Anoro Ellipta$113$40,82763 claims
Lilly USA, LLCMounjaro$15$18,96918 claims
AstraZenecaSymbicort$14$2,77912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 2,103 family providers in Arkansas.

Other family in Heber Springs

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →